Talasing, Salvador C.

HRN: 09-48-04  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
AZITHROMYCIN 500MG TABLET (TAB)
10/23/2023
10/27/2023
PO
500mg
Q24h
Presumptive TB, COPD, CAP-LR
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: